News

ROCKVILLE, Md., Feb. 18, 2022 – OncoC4, Inc. is elated to announce that its co-founder and Chief Medical Officer, Dr. Pan […]

ROCKVILLE, Md., Nov. 09, 2021 — OncoC4, Inc., a clinical stage biopharma company focusing on immuno-oncology of cancer, reports a […]

SHANGHAI and ROCKVILLE, Md., May 26, 2021 — WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, […]

KENILWORTH, N.J., & ROCKVILLE, Md.–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and OncoImmune, a privately-held, […]

OncoImmune, Inc. announced today that it has dosed the first patient in the first-in-human clinical trial of ONC-392, its novel, […]